Anti-PD-1 therapy triggers Tfh cell–dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes
Mathilde Ruggiu(Inserm), Philippe Bousso(Inserm), Zacarias Garcia(Inserm), L Feldmann(Inserm), Capucine L. Grandjean(Inserm), Erica Russo(Inserm), Béatrice Corre(Inserm), Marion V. Guérin(Inserm), Ruby Alonso(Center of Molecular Immunology (Cuba)), Fabrice Lemaı̂tre(Inserm), Mathilde Dusséaux(Institut Pasteur), Margot Bardou(Inserm)
Cited by 40
Related Papers
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17–secreting T cells
|Blood|2010|1k
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
|Proceedings of the National Academy of Sciences|2018|948
Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes
|Nature Immunology|2003|617